Multidrug Resistance Protein MRP2 Contributes to Blood-Brain Barrier Function and Restricts Antiepileptic Drug Activity

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/JPET.103.049858PMID 12663688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bile salt transporters.

  2002cited by this paper
• Xenobiotic efflux pumps in isolated fish brain capillaries.

  2002cited by this paper
• Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats.

  2002cited by this paper
• Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.

  2002cited by this paper
• A comparison of extracellular levels of phenytoin in amygdala and hippocampus of kindled and non-kindled rats

  2002cited by this paper
• Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition

  2002influential reference
• Limbic Seizures Induce P-Glycoprotein in Rodent Brain: Functional Implications for Pharmacoresistance

  2002influential reference
• Permeability of porcine blood brain barrier to somatostatin analogues

  2002cited by this paper
• The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS Disorders

  2002cited by this paper
• P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.

  2002cited by this paper
• Drug resistance molecules: lessons from oncology.

  2002cited by this paper
• From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance

  2001cited by this paper
• Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.

  2001cited by this paper
• P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain

  2001cited by this paper
• In Vivo Evidence for P‐Glycoprotein–Mediated Transport of Phenytoin at the Blood–Brain Barrier of Rats

  2001cited by this paper
• Lack of robust anticonvulsant effects of muscimol microinfusions in the anterior substantia nigra of kindled rats.

  2001cited by this paper
• Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters.

  2001cited by this paper
• Overexpression of Multiple Drug Resistance Genes in Endothelial Cells from Patients with Refractory Epilepsy

  2001cited by this paper
• Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain

  2001cited by this paper
• Role of transport proteins in drug absorption, distribution and excretion

  2001cited by this paper
• P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.

  2000cited by this paper
• Xenobiotic transport across isolated brain microvessels studied by confocal microscopy.

  2000cited by this paper
• Functional expression of p‐glycoprotein and multidrug resistance‐associated protein (mrp1) in primary cultures of rat astrocytes

  2000cited by this paper
• Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin-resistant kindled rats.

  2000cited by this paper
• P-Glycoprotein, a gatekeeper in the blood-brain barrier.

  1999influential reference
• Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.

  1999cited by this paper
• The multidrug resistance protein family.

  1999cited by this paper
• Multidrug-resistance transporters.

  1999cited by this paper
• Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2'R, 3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV).

  1998cited by this paper
• Multidrug Resistance Protein

  1998cited by this paper
• Mrp1 Multidrug Resistance‐Associated Protein and P‐Glycoprotein Expression in Rat Brain Microvessel Endothelial Cells

  1998cited by this paper
• Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene

  1996cited by this paper
• The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models.

  1991cited by this paper
• The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds.

  1991cited by this paper
• Practical aspects of using microdialysis for determination of brain interstitial concentrations

  1991influential reference
• The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models.

  1991cited by this paper
• Microdialysis in the neurosciences

  1991cited by this paper
• Kindling: basic mechanisms and clinical validity.

  1990influential reference
• Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds.

  1990cited by this paper
• Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport

  1985influential reference
• Distribution of valproate across the interface between blood and cerebrospinal fluid.

  1978cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972cited by this paper

• Seizure prophylaxis and its impact on busulfan pharmacokinetics and dosing in a novel timed sequential protocol: MD Anderson experience.

  2025cites this paper
• An Evaluation of Cation–Chloride Cotransporters NKCC1 and KCC2 in Carbamazepine-Resistant Rats

  2025influential citation
• Dolutegravir induces endoplasmic reticulum stress at the blood–brain barrier

  2025cites this paper
• Cross-sectional and longitudinal associations of circulating bile acids and dementia: a systematic review.

  2025cites this paper
• Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System

  2024cites this paper
• The impact of ATP-binding cassette transporters in the diseased brain: Context matters

  2024cites this paper
• SEW2871 reduces seizures via the sphingosine 1‐phosphate receptor‐1 pathway in the pentylenetetrazol and phenobarbitone kindling model of drug‐refractory epilepsy

  2024cites this paper
• Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment.

  2023cites this paper
• ATP-binding cassette (ABC) drug transporters in the developing blood–brain barrier: role in fetal brain protection

  2022cites this paper
• Vascular endothelial cells: a fundamental approach for brain waste clearance.

  2022cites this paper
• Factors influencing the blood-brain barrier permeability.

  2022cites this paper
• Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted Pharmaceutics

  2022cites this paper
• Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients

  2022cites this paper
• Carbamazepine Shows Plasma and Tissue Pharmacokinetic Interactions with Ajuga bracteosa Extract in Rats

  2021cites this paper
• Drug Transporters: Efflux

  2021cites this paper
• Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders.

  2020cites this paper
• Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options

  2020cites this paper
• Possible interplay between the theories of pharmacoresistant epilepsy

  2020cites this paper
• A review of the drug-drug interactions of the antiepileptic drug brivaracetam.

  2020cites this paper
• The potential role of human multidrug resistance protein 1 (MDR1) and multidrug resistance-associated protein 2 (MRP2) in the transport of Huperzine A in vitro

  2020cites this paper
• Estudio de genes candidatos sobre la efectividad y seguridad de la medicación anticonvulsiva en un grupo de pacientes colombianos afectados de epilepsia

  2020influential citation
• Contributions of Drug Transporters to Blood-Brain Barriers.

  2019cites this paper
• Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport

  2019cites this paper
• Ausencia de asociación entre polimorfismos de los genes ABCB1 c.C3435T y ABCC2 c. -24C>T con epilepsia farmacorresistente en pacientes peruanos.

  2019influential citation
• Blood–Brain Barrier in Disease States

  2019cites this paper
• ATP-binding Cassette Exporters: Structure and Mechanism with a Focus on P-glycoprotein and MRP1.

  2019cites this paper
• Design, synthesis and anticonvulsant evaluation of fluorinated benzyl amino enaminones.

  2019cites this paper
• A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment

  2019cites this paper
• Polymorphisms in potential mercury transporter ABCC2 and neurotoxic symptoms in populations exposed to mercury vapor from goldmining.

  2019cites this paper
• Pannexin-1 channels contribute to seizure generation in human epileptic brain tissue and in a mouse model of epilepsy

  2018cites this paper
• The Role of Eukaryotic ABC-Transporters in Eliciting Neutrophil infiltration during Streptococcus pneumoniae infection

  2018cites this paper
• Transporters MRP1 and MRP2 Regulate Opposing Inflammatory Signals To Control Transepithelial Neutrophil Migration during Streptococcus pneumoniae Lung Infection

  2018cites this paper
• Farmacogenética de reacciones adversas a fármacos antiepilépticos

  2018cites this paper
• Efflux proteins at the blood–brain barrier: review and bioinformatics analysis

  2018cites this paper
• The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy

  2018influential citation
• 2018-0705 Transporters MRP 1 and MRP 2 Regulate Opposing Inflammatory Signals To Control Transepithelial Neutrophil Migration during Streptococcus pneumoniae Lung Infection

  2018cites this paper
• 1 Structure and mechanism of ATP-binding cassette exporters

  2017cites this paper
• Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

  2017cites this paper
• Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers

  2017influential citation
• Exploring the Carbamazepine Interaction with Human Pregnane X Receptor and Effect on ABCC2 Using in Vitro and in Silico Approach

  2017cites this paper
• P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human Epilepsy.

  2017cites this paper
• Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?

  2017cites this paper
• SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers

  2017cites this paper
• Computer-Aided Recognition of ABC Transporters Substrates and Its Application to the Development of New Drugs for Refractory Epilepsy.

  2017cites this paper
• Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review

  2017cites this paper
• Morphine and the blood-brain barrier: diffusion, uptake, or efflux?

  2017cites this paper
• The role of glucuronidation in drug resistance.

  2016cites this paper
• Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data.

  2016cites this paper
• Targeting Chemotherapy Resistance in Glioblastoma Through Modulation of ABC Transporters

  2016cites this paper
• Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain

  2016cites this paper
• Topología molecular aplicada al reconocimiento de sustratos de la Proteína de Resistencia del Cáncer de Mama (BCRP)

  2016influential citation
• Discovering New Antiepileptic Drugs Addressing the Transporter Hypothesis of Refractory Epilepsy: Ligand-Based Approximations

  2016cites this paper
• ABC transporters at the blood–brain barrier

  2016cites this paper
• Modulation of Expression and Activity of ABC Transporters by the Phytoestrogen Genistein. Impact on Drug Disposition.

  2016cites this paper
• Beitrag ATP-abhängiger Transportproteine zur Pharmakoresistenz von Patienten mit mesialer Temporallappenepilepsie

  2016cites this paper
• Therapeutic Monitoring of Anticonvulsants: Use of Saliva as Biological Fluid

  2016cites this paper
• Neural overexpression of multidrug resistance-associated protein 1 and refractory epilepsy: a meta-analysis of nine studies

  2016influential citation
• Role and modulation of drug transporters in HIV-1 therapy.

  2016cites this paper
• Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier.

  2016cites this paper
• Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline

  2015cites this paper
• Involvement of p38 MAPK in the Drug Resistance of Refractory Epilepsy Through the Regulation Multidrug Resistance-Associated Protein 1

  2015cites this paper
• The Expression and Function of ABC Transporters at the Blood-Brain Barrier

  2015cites this paper
• Glutamate-Mediated Upregulation of the Multidrug Resistance Protein 2 in Porcine and Human Brain Capillaries

  2015cites this paper
• Lack of association between ABCC 2 polymorphisms and plasma carbamazepine concentrations or pharmacoresistance in Chinese patients with epilepsy

  2015cites this paper
• Regulation of Human Hepatic Drug Transporter Activity and Expression by Diesel Exhaust Particle Extract

  2015cites this paper
• Study of the antiepileptic drugs transport through the immature blood-brain barrier

  2015influential citation
• Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.

  2015cites this paper
• Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy

  2015cites this paper
• The organic anion transport inhibitor probenecid increases brain concentrations of the NKCC1 inhibitor bumetanide.

  2015cites this paper
• Regulation of efflux transporter expression and function in neural injury and inflammation

  2015cites this paper
• Characterization of blood-brain barrier disruption in a focal model of neuromyelitis optica

  2015cites this paper
• New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition

  2015cites this paper
• Multidrug resistance-associated protein 2 (MRP2) and oxaliplatin transport

  2015cites this paper
• SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy.

  2015cites this paper
• Pharmacogenetics of adverse reactions to antiepileptic drugs.

  2015cites this paper
• Characterization of multidrug transporter-mediated efflux of avermectins in human and mouse neuroblastoma cell lines.

  2015cites this paper
• In Vitro and In Vivo Regulation of Pro-inflammatory Cytokines and Drug Efflux Transporters by Signal Transduction Pathways in Glial Cells: Implications in HIV-1 Neuropathogenesis and its Treatment

  2015cites this paper
• Chronic administration of phenytoin induces efflux transporter overexpression in rats

  2014cites this paper
• The Blood Brain Barrier — Regulation of Fatty Acid and Drug Transport

  2014cites this paper
• Role of CNS transporters in the pharmacotherapy of HIV-1 associated neurological disorders.

  2014cites this paper
• Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.

  2014cites this paper
• Epilepsy : A Complex Disease with Several Potential Therapeutic Targets Epilepsy and pharmacogenetics

  2014cites this paper
• Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) Restrict Oral Availability and Brain Accumulation of the PARP Inhibitor Rucaparib (AG-014699)

  2014cites this paper
• Disease Influence on BBB Transport in Neurodegenerative Disorders

  2014cites this paper
• CNS transporters and drug delivery in epilepsy.

  2014cites this paper
• Targeted Resequencing of Epilepsy Genes: A Pharmaco-Therapeutic Perspective

  2014cites this paper
• Changes in the ATP-binding cassette efflux transporters of the blood-brain barrier in glioma challenge

  2014cites this paper
• ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to antiepileptic drugs in Asia Pacific epilepsy cohorts.

  2014cites this paper
• Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response

  2014cites this paper
• Antiepileptic drugs: Energy-consuming processes governing drug disposition.

  2014cites this paper
• Pharmacoresistance in Epilepsy

  2013cites this paper
• Genetic Variations of ABCC2 Gene Associated with Adverse Drug Reactions to Valproic Acid in Korean Epileptic Patients

  2013cites this paper
• Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.

  2013cites this paper
• Experimental Models of Disseminated Scedosporiosis with Cerebral Involvement

  2013cites this paper
• Probenecid: an emerging tool for neuroprotection.

  2013cites this paper
• Multidrug resistance-associated protein 2 (MRP2/ABCC2)

  2013cites this paper
• Applications of Nanotechnology in Epilepsy

  2013cites this paper
• Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME

  2013cites this paper
• Drug Transporters At Brain Barriers

  2013cites this paper
• P‐glycoprotein and multidrug resistance‐associated protein 2 are oppositely altered in brain of rats with thioacetamide‐induced acute liver failure

  2013cites this paper